Understanding and assessing the impact of end-stage renal disease on quality of life: A systematic review of the content validity of self-administered instruments used to assess health-related quality of life in end-stage renal disease

Patient

Volumn 4, Issue 1, 2011, Pages 19-30

  Glover, Cheryl ^a   Banks, Pauline ^a   Carson, Amanda ^a   Martin, Colin R ^a   Duffy, Tim ^a  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

CLINICAL ASSESSMENT TOOL; CONTENT VALIDITY; EUROQOL 5 DIMENSION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIFE SATISFACTION INDEX; NOTTINGHAM HEALTH PROFILE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REVIEW; SHORT FORM 36; SICKNESS IMPACT PROFILE; SYSTEMATIC REVIEW; WHO QOL ASSESSMENT;

HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF REPORT;

EID: 79951665808     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11584650-000000000-00000     Document Type: Review

References (58)

1. Ken Farrington AH, Casula A, Ansell D, et al. UK Renal Registry 11th Annual Report. Bristol: UK Renal Registry, 2008 [online]. Available from URL: . com/Reports/2008.html [Accessed 2011 Jan 6]
2. Cross Party Group on Kidney Disease. Renal disease in Scotland: a strategy for future management. Edinburgh: The Scottish Parliament, 2004 [online]. Available from URL: Renal-Disease-in-Scotland-A-Strategy-For-Future- Man agement-April-2004.sflb.ashx [Accessed 2010 Dec 20]
3. Levy J, Pusey C, Singh A. Fast facts: renal disorders. Oxford: Health Press, 2006
4. Haynes SN, Richard DCS, Kubany ES. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess 1995; 7 (3): 238-47
5. Bowling A. Measuring health: a review of quality of life measurement scales. 3rd ed. Maidenhead: Open University Press, 2005
6. Phillips D. Quality of life: concept, policy and practice. London: Routledge, 2006
7. WHOQOL. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41 (10): 1403-9
8. Molzahn AE, Northcott HC, Dossetor JB. Quality of life of individuals with end stage renal disease: perceptions of patients, nurses, and physicians.ANNAJ 1997; 24 (3): 325-33; discussion 34-5
9. Slevin ML, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or the patient. Br J Cancer 1988; 57 (1): 109-12 (Pubitemid 18067115)
10. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948
11. Mapes DL, Lopes AA, Satayathum S, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003 Jul; 64 (1): 339-49 (Pubitemid 36714189)
12. O'Shaughnessy DV, Elder GJ. Review article: patient-level outcomes. The missing link. Nephrology (Carlton) 2009 Jun; 14 (4): 443-51
13. Unruh ML, Weisbord SD, Kimmel PL. Health-related quality of life in nephrology research and clinical practice. Semin Dial 2005 Mar-Apr; 18 (2): 82-90 (Pubitemid 40522074)
14. Moinpour CM, Lyons B, Schmidt SP, et al. Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases. Quality Life Res 2000; 9 (2): 219-31
15. Bass EB, Jenckes MW, Fink NE, et al. Use of focus groups to identify concerns about dialysis. Med Decis Making 1999; 19 (3): 287-95 (Pubitemid 29321270)
16. Juergensen E, Wuerth D, Finkelstein SH, et al. Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol 2006 Aug; 1 (6): 1191-6
17. Cukor D, Cohen SD, Peterson RA, et al. Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness. J Am Soc Nephrol 2007 Dec; 18 (12): 3042-55 (Pubitemid 350223964)
18. Wuerth D, Finkelstein SH, Finkelstein FO. Psychosocial assessment of the patient on chronic peritoneal dialysis: an overview. Adv Chronic Kidney Dis 2007; 14 (4): 353-7 (Pubitemid 47451831)
19. Wu AW, Fink NE, Cagney KA, et al. Developing a healthrelated quality-of-life measure for end-stage renal disease: the CHOICE Health Experience Questionnaire. Am J Kidney Dis 2001 Jan; 37 (1): 11-21 (Pubitemid 32055013)
20. Weisbord SD. Symptoms and their correlates in chronic kidney disease. Adv Chronic Kidney Dis 2007; 14 (4): 319-27 (Pubitemid 47451834)
21. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30 (6): 473-83
22. EuroQol: a new facility for the measurement of healthrelated quality of life. The EuroQol Group. Health Policy 1990; 16 (3): 199-208
23. Development of the World Health Organization WHOQOL- BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998; 28 (3): 551-8
24. Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19 (8): 787-805 (Pubitemid 11021288)
25. Liem YS, Bosch JL, Arends LR, et al. Quality of life assessed with the medical outcomes study short form 36-item health survey of patients on renal replacement therapy: a systematic review andmeta-analysis. Value Health 2007; 10: 390-7 (Pubitemid 47481110)
26. Cameron JI, Whiteside C, Katz J, et al. Differences in quality of life across renal replacement therapies: a metaanalytic comparison. Am J Kidney Dis 2000; 35 (4): 629-37 (Pubitemid 30185507)
27. Haycox A, Jones D. The cost effectiveness of renal provision in the UK. J Manag Med 1996; 10 (1): 6-15
28. Fan SL, Sathick I, McKitty K, et al. Quality of life of caregivers and patients on peritoneal dialysis. Nephrol Dial Transplant 2008 May; 23 (5): 1713-9 (Pubitemid 351767740)
29. Smith GC, Trauer T, Kerr PG, et al. Prospective psychosocial monitoring of living kidney donors using the SF-36 health survey. Transplantation 2003 Sep; 76 (5): 807-9 (Pubitemid 37140224)
30. Shrestha A, Vallance C, McKane WS, et al. Quality of life of living kidney donors: a single-center experience. Transplant Proc 2008 Jun; 40 (5): 1375-7 (Pubitemid 351853178)
31. Bilgic A, Akman B, Sezer S, et al. Predictors for quality of life in continuous ambulatory peritoneal dialysis patients. Nephrology 2008; 13 (7): 587-92
32. Franke GH, Trampenau C, Reimer J, et al. Switching from cyclosporine to tacrolimus leads to improved diseasespecific quality of life in patients after kidney transplantation. Transplant Proc 2006 Jun; 38 (5): 1293-4
33. Lee AJ, Morgan CL, Conway P, et al. Characterisation and comparison of health-related quality of life for patients with renal failure. Curr Med Res Opin 2005; 21 (11): 1777-83 (Pubitemid 41667245)
34. Manns B, Johnson JA, Taub K, et al. Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol 2003; 60 (5): 341-51 (Pubitemid 37407692)
35. Manns BJ, Johnson JA, Taub K, et al. Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J 2002; 48 (5): 565-9
36. Theodora K, Christina D, Tania F, et al. Looking in to the factors affecting renal patients' quality of life. EDTNA J 1996; 23 (3): 19-21 (Pubitemid 26381317)
37. Padrao MB, Sens YAS. Quality of life of living kidney donors in Brazil: an evaluation by the short form-36 and the WHOQOL-bref questionnaires. Clin Transplant 2009 Aug; 23 (5): 621-7
38. Ginieri-Coccossis M, Theofilou P, Synodinou C, et al. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: investigating differences in early and later years of current treatment. BMC Nephrol 2008; 9: 14
39. Niu S-F, Li IC. Quality of life of patients having renal replacement therapy. J Adv Nurs 2005; 51 (1): 15-21 (Pubitemid 40828721)
40. McMahon LP, Mason K, Skinner SL, et al. Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure. Nephrol Dial Transplant 2000; 15 (9): 1425-30
41. Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, et al. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life StudyGroup of the Spanish Society of Nephrology. J Am Soc Nephrol 2000; 11 (2): 335-42 (Pubitemid 30064857)
42. Rebollo P, Ortega F, Baltar JM, et al. Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant 2000; 14 (3): 199-207 (Pubitemid 30242954)
43. Hays RD, Kallich JD,Mapes DL, et al. Development of the kidney-disease quality-of-life (KDQOL) Instrument. Qual Life Res 1994 Oct; 3 (5): 329-38 (Pubitemid 24358749)
44. Laupacis A, Muirhead N, Keown P, et al. A disease-specific questionnaire for assessing quality-of-life in patients onhemodialysis. Nephron 1992; 60 (3): 302-6
45. Franke GH, Reimer J, Kohnle M, et al. Quality of life in end-stage renal disease patients after successful kidney transplantation: development of the ESRD symptom checklist-transplantation module. Nephron 1999 Sep; 83 (1): 31-9 (Pubitemid 29417644)
46. Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 1985; 8 (1): 15-24
47. Barotfi S, Molnar MZ, Almasi C, et al. Validation of the Kidney Disease Quality of Life-Short Form questionnaire in kidney transplant patients. J Psychosomat Res 2006 May; 60 (5): 495-504
48. Martin CR, Thompson DR. Prediction of quality of life in patients with end-stage renal disease. Br J Health Psychol 2000; 5: 41-55 (Pubitemid 30088784)
49. Lefebvre P, Vekeman F, Sarokhan B, et al. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. Curr Med Res Opin 2006 Oct; 22 (10): 1929-37 (Pubitemid 44663398)
50. Provenzano R, Garcia-Mayol L, Suchinda P, et al. Onceweekly epoetin alfa for treating the anemia of chronic kidney disease. Clinical Nephrol 2004 Jun; 61 (6): 392-405 (Pubitemid 38787334)
51. Neto JFR, Ferraz MB, Cendoroglo M, et al. Quality of life at the initiation of maintenance dialysis treatment: a comparison between the SF-36 and the KDQ questionnaires. Qual Life Res 2000 Feb; 9 (1): 101-7 (Pubitemid 30670653)
52. Sesso R, Yoshihiro MM. Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial Transplant 1997 Oct; 12 (10): 2111-6 (Pubitemid 27423250)
53. Franke GH, Yucetin L, Yaman H, et al., editors. Diseasespecific quality of life in Turkish patients after successful kidney transplantation. 8th Meeting of the Turkish- Transplantation-Society; 2005 Jun 22-24; Ankara. New York: Elsevier Science Inc., 2006
54. Franke GH, Reimer J, Philipp T, et al. Aspects of quality of life through end-stage renal disease. Qual Life Res 2003 Mar; 12 (2): 103-15 (Pubitemid 36255776)
55. Cetingok M, Winsett RP, Hathaway DK. A comparative study of quality of life among the age groups of kidney transplant recipients. Prog Transplant 2004; 14 (1): 33-8 (Pubitemid 38375386)
56. Johnson CD, Wicks MN, Milstead J, et al. Racial and gender differences in quality of life following kidney transplantation. Image J Nurs Sch 1998; 30 (2): 125-30
57. Kouidi E, Iacovides A, Iordanidis P, et al. Exercise renal rehabilitation program: psychosocial effects. Nephron 1997; 77 (2): 152-8 (Pubitemid 27440404)
58. Dunn SA, Lewis SL, Bonner PN, et al. Quality of life for spouses of CAPD patients. ANNA J 1994; 21 (5): 237-46